Tag:
Esperion Therapeutics
Latest Headlines
Latest Headlines
Esperion revives cholesterol R&D pact with Cleveland Clinic
The re-born Esperion Therapeutics is once again teaming up with researchers at the Cleveland Clinic to find new cholesterol therapies. The deal revives a relationship that was terminated when Pfizer,
Esperion gets second shot as an independent drugmaker
After getting squashed in Pfizer's restructuring crunch, Esperion Therapeutics is reopening this week. The company, which specializes in cardiovascular and metabolic disease work, is hiring about 10
Pfizer spins off Esperion as VCs ante up $22.75M
Pfizer has spun of Esperion Therapeutics into a new biotech company aiming to develop new therapies for cardiovascular and metabolic disease. A syndicate of investors funded the deal. Pfizer sold
